Drug intelligence / Profile preview

poly(L-glutamic acid)-grafted hyaluronan

Development stage
Preclinical
Lead developer
Tokyo Denki University
Modality
Peptides, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Intraarticular
01

Overview

Poly(L-glutamic acid)-grafted hyaluronan (PGA-g-HA) is a synthetic hyaluronan derivative designed for intra-articular injection to treat osteoarthritis. By grafting poly(L-glutamic acid) onto a hyaluronan backbone, the molecule achieves significantly enhanced resistance to enzymatic degradation by hyaluronidase, addressing the short half-life of conventional hyaluronic acid viscosupplements. In preclinical studies, PGA-g-HA demonstrated viscoelastic properties similar to high-molecular-weight hyaluronan and exhibited potent anti-inflammatory activity by inhibiting IL-1β-mediated inflammatory responses in chondrocytes. It has shown superior chondroprotective effects in rat models of knee osteoarthritis compared to unmodified hyaluronan, suggesting its potential as a durable, disease-modifying treatment for joint degeneration.

Other names
poly(L-glutamic acid)-g-hyaluronanPGA-grafted hyaluronanPGA-grafted HA

Beyond the preview

Go deeper on poly(L-glutamic acid)-grafted hyaluronan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on poly(L-glutamic acid)-grafted hyaluronan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call